Your browser doesn't support javascript.
loading
An update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
Chang, Wan-Chun; Hung, Shuen-Iu; Carleton, Bruce C; Chung, Wen-Hung.
Affiliation
  • Chang WC; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia , Vancouver, British Columbia, Canada.
  • Hung SI; British Columbia Children's Hospital Research Institute , Vancouver, British Columbia, Canada.
  • Carleton BC; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital , Linkou, Taipei, Taiwan.
  • Chung WH; College of Medicine, Chang Gung University , Taoyuan, Taiwan.
Expert Opin Drug Metab Toxicol ; 16(8): 723-734, 2020 Aug.
Article in En | MEDLINE | ID: mdl-32510242

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenytoin / Epilepsy / Anticonvulsants Type of study: Prognostic_studies Limits: Humans Language: En Journal: Expert Opin Drug Metab Toxicol Journal subject: METABOLISMO / TOXICOLOGIA Year: 2020 Document type: Article Affiliation country: Canadá Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenytoin / Epilepsy / Anticonvulsants Type of study: Prognostic_studies Limits: Humans Language: En Journal: Expert Opin Drug Metab Toxicol Journal subject: METABOLISMO / TOXICOLOGIA Year: 2020 Document type: Article Affiliation country: Canadá Country of publication: Reino Unido